Use of Antibiotic Carrier in Acute Periprosthetic Infections (APPI) of Total Knee Replacements

NCT02107924 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2014-11-26

No results posted yet for this study

Summary

The purpose of the study is to gather information on the use of Stimulan, the surgery, and anitbiotics to whetether the APPI has decreased or shown improvement when compared to study participants who did not receive Stimulan during their revision total knee replacement surgery.

Conditions

Interventions

PROCEDURE

APPI of TKR-Stimulan

Sponsors & Collaborators

  • The Methodist Hospital Research Institute

    collaborator OTHER
  • Michael Muldoon, M.D.

    lead OTHER

Principal Investigators

  • Michael P Muldoon, MD · Sharp HealthCare

  • David R Lionberger, MD · Southwest Orthopedic Group, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02107924 on ClinicalTrials.gov